CTN+ to lead Canada’s HIV and STBBI clinical trial infrastructure with $25 million investment from CIHR
On July 12th, 2024, the Canadian Institutes for Health Research (CIHR) announced a $25 million...
Learn MoreMarch 12, 2024
Maintaining Momentum: CTN Renewal
Since 1990, the CTN has supported impactful research that has reduced new infections and improved...
Learn More
CTN at CAHR 2024
CAHR 2024 will take place in London, Ontario from Thursday, April 25 to Sunday, April...
Learn More
Unmasking the silent struggle: Living with chronic pain in the shadow of HIV
World AIDS Day December 1 is World AIDS Day, a global event that transcends borders...
Learn More
A call for community engagement: Exploring the harms and benefits of molecular HIV surveillance
“The first letter in HIV stands for Human,” writes Dr. Alexander McClelland in a co-authored...
Learn More
A Legacy of Integrity: Honouring Rosie’s 25 Years with the CTN
The first CTN study that Rosie worked on was the CTN164 STI study – that...
Learn More
The Cannabis Conundrum
A Brief History of Medical Cannabis in Canada For centuries, cannabis has been used as...
Learn More
Hepatitis C cure does not remove all risks, CTN investigators find
CTN Investigators Drs. Naveed Janjua (Canadian lead) and Sofia Bartlett, along with a team of...
Learn More
Using mRNA technology to arm the immune system against HIV
Development of mRNA vaccines has opened a brand-new tool for researchers to use in the...
Learn More